Neurologic dysfunction is a common side effect of many chemotherapy drugs. For several agents neurotoxicity is common, severe, and can be dose limiting. As the list of newer chemotherapy agents and systemic targeted therapies grows, so does the number and variety of potential neurotoxicities. This article reviews the clinical features of chemotherapy-induced syndromes involving the central and peripheral nervous systems.
|Original language||English (US)|
|Number of pages||18|
|Journal||CONTINUUM Lifelong Learning in Neurology|
|State||Published - May 30 2011|
ASJC Scopus subject areas
- Clinical Neurology